Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant - PA: Genetics (Bridge Funding: Research Priorities)

Institut de recherches cliniques de Montréal

$100,000.00

Hox pioneering activity in development and disease

FY 2023-24

Summary
Genes of the Hox family are critical for the proper development of the embryo as illustrated by the numerous congenital malformation associated with mutations in Hox genes. It is therefore critical to understand how these genes function. Previous work provided evidence that the Hox proteins act as pioneering factors, i.e. factors that can selectively open the chromatin allowing for differential gene activity. This differential gene activity is critical for the generation of different cell types in the developing embryo. The mechanism by which Hox proteins achieve this pioneering activity remains unknown. Using the mouse developing limb as a model system, we propose to identify this mechanism. Our work will help understanding the molecular basis of human congenital malformations associated with mutations in Hox genes.
Program
Operating Grant - PA: Genetics (Bridge Funding: Research Priorities)
Location
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
503904
Name
Kmita Marie T
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Cell Biology - Disease
Projecttitle
Hox pioneering activity in development and disease
Programtype2
Operating Grants
Orgnameinp2
Institut de recherches cliniques de Montréal
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - PA: Genetics (Bridge Funding: Research Priorities)
Keyworddelim
Congenital Malformations; Embryogenesis; Hox Genes; Human Syndromes; Pioneer Factors; Swi/Snf; Transcriptional Regulation
Abstract
Genes of the Hox family are critical for the proper development of the embryo as illustrated by the numerous congenital malformation associated with mutations in Hox genes. It is therefore critical to understand how these genes function. Previous work provided evidence that the Hox proteins act as pioneering factors, i.e. factors that can selectively open the chromatin allowing for differential gene activity. This differential gene activity is critical for the generation of different cell types in the developing embryo. The mechanism by which Hox proteins achieve this pioneering activity remains unknown. Using the mouse developing limb as a model system, we propose to identify this mechanism. Our work will help understanding the molecular basis of human congenital malformations associated with mutations in Hox genes.
Competitiondate
202403
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kmita, Marie T
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~
Institut de recherches cliniques de Montréal - $100,0… | Canada Spends